Market Cap

ADC Therapeutics SA Market Capitalization:

$436.0 Million

USD as of Jan. 1, 2026

business ADC Therapeutics SA Company Profile

ADC Therapeutics SA Main Stock Listing

NYSE: ADCT

Market Capitalization History of ADC Therapeutics SA

Market capitalizations are calculated from the opening stock price at the beginning of each month.

Top Competitors by Market Capitalization

Industry: Biotechnology
Company Market Cap (USD)
Novo Nordisk $158.96 B
Vertex Pharmaceuticals Incorporated $115.92 B
CSL Limited $95.75 B
Regeneron Pharmaceuticals, Inc. $82.28 B
Marinomed Biotech AG $70.11 B
Sector: Healthcare
Company Market Cap (USD)
Lilly $968.50 B
Johnson & Johnson $499.57 B
AbbVie $405.28 B
Roche $332.12 B
UnitedHealth Group $304.72 B

Yearly evolution of ADC Therapeutics SA market cap

Date Market Cap YoY Change
Jan. 1, 2026 $436.0 M 156.24%
Jan. 1, 2025 $170.2 M 3.95%
Jan. 1, 2024 $163.7 M -57.83%
Jan. 1, 2023 $388.2 M -69.48%
Jan. 1, 2022 $1.27 B -44.38%
Jan. 1, 2021 $2.29 B

Market capitalization is calculated from the opening stock price at the beginning of each year.

ADC Therapeutics SA Categories

Switzerland languages Healthcare languages Biotechnology
Switzerland Healthcare Switzerland Biotechnology

Stocks & Indices

ADC Therapeutics SA has the following listings and related stock indices.


Stock: NYSE: ADCT

What is a company's market capitalization?

The market capitalization of a company, more simply referred to as "market cap", is the total market value of a publicly traded company's outstanding shares. It is often considered as a key indicator of what a company is worth.